Terlipressin 0.1 mg/ml Injection Ampoule, ₹300/unit | Tradoi
Healthcare & Medical › Pharmaceutical Products
Terlipressin 0.1 mg/ml Injection Ampoule — manufactured in Bhopal, Madhya Pradesh by Eustoma Laboratories Pvt. Ltd. Tradoi-verified manufacturer at ₹300/units, MOQ 10 units.
Product Overview
Terlipressin 0.1 mg/ml injection, supplied in ampoules for intravenous administration, is produced for institutional buyers such as hospitals, clinics, and healthcare networks, targeting hepatorenal syndrome treatment.
Detailed Description
Terlipressin 0.1 mg/ml injection is a pharmaceutical product formulated for intravenous administration, supplied in ampoules. Each ml contains Terlipressin BP 0.1 mg (as Terlipressin Acetate) with Water for Injections IP q.s. as excipients. This product is made in-house at our Bhopal, Madhya Pradesh facility, ensuring consistent quality and supply. It is specifically indicated for the treatment of hepatorenal syndrome, providing a critical therapeutic option for medical facilities managing this condition. Procurement managers can rely on this product for consistent supply in their inventory management. Our manufacturing processes adhere to stringent quality standards, as evidenced by our AN ISO 9001:2015 certification. The product is marketed by Eustoma Laboratories Pvt. Ltd. under manufacturing license number K. M. 001/2019, ensuring compliance with regulatory requirements for pharmaceutical products.
Product Details
| Category | Healthcare & Medical |
|---|---|
| Sub-Category | Pharmaceutical Products |
| Product Type | Injectables & Infusions |
| Price | ₹300 per unit |
| Minimum Order Quantity | 10 units |
| Unit | units |
| HSN/SAC Code | 3004 |
| Country of Origin | India |
Key Features
- API Name: Terlipressin – a critical active pharmaceutical ingredient for specific medical treatments.
- Concentration: 0.1 mg/ml – precisely formulated for accurate dosage and therapeutic efficacy.
- Dosage Form: Injection – designed for rapid and effective systemic delivery.
- Composition per ml: Terlipressin BP 0.1 mg (As Terlipressin Acetate) – ensures adherence to pharmacopoeial standards.
- Excipients: Water for Injections IP q.s. – formulated with high-purity water for safe parenteral use.
- Route of Administration: Intravenous – suitable for direct administration into the bloodstream for immediate action.
- Container Type: Ampoule – sterile, single-dose packaging for secure and contamination-free delivery.
- Target Condition: Hepatorenal syndrome – specifically indicated for managing this severe medical condition.
- Company Certification: AN ISO 9001:2015 Certified Company – demonstrates adherence to international quality management standards.
Applications & Use Cases
- Hospitals: For critical care units and nephrology departments treating hepatorenal syndrome.
- Clinics: Specialised clinics requiring specific pharmaceutical agents for patient care.
- Healthcare Networks: Centralised procurement for multiple facilities within a network.
- Export Houses: For international distribution to healthcare providers and markets.
- Emergency Medical Services: For rapid intervention in acute medical scenarios requiring Terlipressin.
Technical Specifications
| Api Name | Terlipressin |
|---|---|
| Excipients | Water for Injections IP q.s. |
| Dosage Form | Powder For Injection |
| Concentration | 0.1 mg/ml |
| Container Type | Ampoule |
| Route Of Administration | Intravenous |
| Mfg Lic No | K. M. 001/2019 |
| Marketed By | Eustoma Laboratories Pvt. Ltd. |
| Suitable For | pharmaceutical distributors and export houses |
| Target Buyers | institutional buyers such as hospitals, clinics, and healthcare networks |
| Target Condition | hepatorenal syndrome |
| Composition Per ML | Terlipressin BP 0.1 mg (As Terlipressin Acetate) |
| Company Certification | AN ISO 9001:2015 Certified Company |
| Manufacturing Location | Bhopal, Madhya Pradesh |
| Minimum Order Quantity Applies | Yes |
Payment Terms
- Full Advance
About the Supplier
Eustoma Laboratories Pvt. Ltd. is a verified B2B supplier based in Bhopal, Madhya Pradesh.
- Tradoi-verified seller
- Experience: 13+ years in business
- Certifications: fssai_license, iec, company_incorporation
View Eustoma Laboratories Pvt. Ltd. supplier profile on Tradoi
Frequently Asked Questions
What is the minimum order quantity for Terlipressin 0.1 mg/ml Injection Ampoule?
The minimum order quantity (MOQ) for Terlipressin 0.1 mg/ml Injection Ampoule is 10 units.
Who manufactures Terlipressin 0.1 mg/ml Injection Ampoule?
Terlipressin 0.1 mg/ml Injection Ampoule is manufactured by Eustoma Laboratories Pvt. Ltd., a Tradoi-verified manufacturer based in Bhopal, Madhya Pradesh.
What are the payment terms for Terlipressin 0.1 mg/ml Injection Ampoule?
Available payment terms for Terlipressin 0.1 mg/ml Injection Ampoule: Full Advance.
What is the price of Terlipressin 0.1 mg/ml Injection Ampoule?
Terlipressin 0.1 mg/ml Injection Ampoule is priced at ₹300 per unit by Eustoma Laboratories Pvt. Ltd.. Minimum order quantity is 10 units. Pricing may vary with order volume — contact the supplier on Tradoi to confirm bulk rates.
How can I buy Terlipressin 0.1 mg/ml Injection Ampoule in bulk?
Terlipressin 0.1 mg/ml Injection Ampoule is available for bulk purchase directly from Eustoma Laboratories Pvt. Ltd. in Bhopal on Tradoi. Submit an RFQ or contact the supplier to discuss volumes above 10 units and negotiate pricing.
You May Also Like
Why Choose Tradoi?
- Every seller completes multi-layer business verification
- Direct contact with verified suppliers for negotiation
- Every supplier business-verified before going live
- Transparent ratings and dedicated dispute resolution
View full product listing on Tradoi